AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

JUDGES SCIENTIFIC PLC

Director's Dealing Jul 27, 2018

7734_dirs_2018-07-27_fa7459f5-5da5-4e47-9c4e-2ee3e26e6b0a.html

Director's Dealing

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0243W

Judges Scientific PLC

27 July 2018

Judges Scientific plc

("Judges Scientific", "Judges", the "Company" or the "Group")

Director dealing

Judges Scientific, a group involved in the buy and build of scientific instrument businesses, announces that is has received notification that on 26 July 2018, Charles Holroyd, Non-Executive Director, purchased 2,016 ordinary shares of 5p each ("Ordinary Shares").

Following the share purchase Charles Holroyd's interest in the Company is 2,016 Ordinary Shares, representing 0.03% of the total voting rights of the Company.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

For further information please contact:

Judges Scientific
David Cicurel, CEO

Brad Ormsby, Group FD
Tel: +44 (0) 203 829 6970
Shore Capital (Nominated Adviser & Broker)
Stephane Auton

Edward Mansfield
Tel: +44 (0) 20 7408 4090
Media enquiries:

Alma PR (Financial Public Relations)
Rebecca Sanders-Hewett

John Coles

Susie Hudson

Sam Modlin
Tel: +44 (0) 20 3865 4219

[email protected]

Director/PDMR Shareholding

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Charles Holroyd

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Judges Scientific plc

b)

LEI

2138004EXWWPTW1JOL31

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares in Judges Scientific plc

GB0032398678

b)

Nature of the transaction

Purchase of shares

c)

Price(s) and volume(s)

Price(s) Volume(s)
2431.8p 411
2480.0p 806
2500.0p 799

d)

Aggregated information

- Aggregated volume

- Price

2,016 Ordinary Shares

2478.1p

e)

Date of the transaction

26/07/2018

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Bradley Ormsby

2

Reason for the notification

a)

Position/status

Group Finance Director

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Judges Scientific plc

b)

LEI

2138004EXWWPTW1JOL31

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares in Judges Scientific plc

GB0032398678

b)

Nature of the transaction

Exercise of options and subsequent sale of shares

c)

Price(s) and volume(s)

Price(s) Volume(s)
1437.5p 30,000
2290.0p 27,914

d)

Aggregated information

- Aggregated volume

- Price

N/A (two separate single transactions

e)

Date of the transaction

05/04/2018

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHBGGDRXBDBGIR

Talk to a Data Expert

Have a question? We'll get back to you promptly.